FDA Approval Sends Shares on a Tear
25 September 2023 - 4:30PM
AllPennyStocks.com
The morning opened up on a high note for this dually-listed
company as it announced U.S. Food and Drug Administration (FDA)
approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501
)....
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Appili Therapeutics (PK) (USOTC:APLIF)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Appili Therapeutics Inc (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Appili Therapeutics Inc (QB) News-Artikel